Physician profile
Karen Ackley
NPI 1356367379
$4,711.86
in general payments reported to CMS, 2019-2025
42 companies · $929 in 2025
The $929 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $469 · 2021: $816 · 2022: $480 · 2023: $847 · 2024: $703 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,478.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $978.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $367.12 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $262.29 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $234.47 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $234.12 | 2019-2024 | Farxiga |
| Corium, LLC | $226.73 | 2022-2025 | Azstarys |
| Dexcom, INC. | $210.49 | 2021-2025 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $187.83 | 2023-2025 | Qelbree, Qelbree |
| Lilly USA, LLC | $186.30 | 2021-2023 | Jardiance, Emgality |
| Abbvie INC. | $176.05 | 2019-2025 | |
| Gilead Sciences, INC. | $174.07 | 2020-2025 | |
| Amarin Pharma, INC. | $170.11 | 2019-2021 | |
| Cranial Technologies, INC | $139.29 | 2019-2025 | Doc Band |
| Glaxosmithkline, LLC. | $122.31 | 2020-2025 | Bexsero, Pediarix, Trelegy Ellipta |
| Alk-Abello, INC | $95.96 | 2023-2025 | Grastek, Odactra, Ragwitek |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Ackley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.